Citadel Advisors’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,300
Closed -$156K 13431
2025
Q4
$156K Buy
+12,300
New +$168K ﹤0.01% 11268
2025
Q2
Sell
-5,000
Closed -$55.1K 13435
2025
Q1
$55.1K Buy
+5,000
New +$55.9K ﹤0.01% 12210
2024
Q4
Sell
-2,800
Closed -$18.7K 14832
2024
Q3
$18.7K Sell
2,800
-400
-13% -$4.1K ﹤0.01% 12825
2024
Q2
$37.3K Buy
3,200
+3,000
+1,500% +$36K ﹤0.01% 12053
2024
Q1
$2.13K Buy
+200
New +$1.59K ﹤0.01% 14040

Other funds holding GHRS

Citadel Advisors's GHRS Position: Q1 2026 in Review

Citadel Advisors increased its GH Research (GHRS) stake by 149% in Q1 2026, buying an estimated $602K and bringing the position to 65,464 shares worth $920K. The position accounts for ﹤0.01% of the portfolio, ranked #7850.

Citadel Advisors first reported a position in GHRS in Q2 2021 and has held it in 18 quarters since. The position peaked at $29.8M in Q4 2021. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Citadel Advisors held 65,464 shares of GH Research worth $920K as of Q1 2026.
  • Citadel Advisors bought 39,206 GH Research shares in Q1 2026, an estimated $602K.
  • GH Research made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7850 holding.
  • Citadel Advisors first reported a position in GH Research in Q2 2021 and has held it in 18 quarters since.
  • Citadel Advisors's GH Research position peaked at $29.8M in Q4 2021.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.